Expression of Follicular Helper T-cell Markers in Primary Cutaneous T-cell Lymphoma

被引:32
作者
Park, Ji-Hye [1 ]
Han, Jae Ho [2 ]
Kang, Hee Young [1 ]
Lee, Eun-So [1 ]
Kim, You Chan [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Dermatol, Suwon 443721, South Korea
[2] Ajou Univ, Sch Med, Dept Pathol, Suwon 443721, South Korea
关键词
follicular helper T cell; primary cutaneous T-cell lymphoma; mycosis fungoides; PD-1; MYCOSIS-FUNGOIDES; PROGRAMMED DEATH-1; NEOPLASTIC-CELLS; TRANSFORMATION; PD-1; ASSOCIATION; FEATURES; DISEASE; CXCL13; AITL;
D O I
10.1097/DAD.0b013e3182a72f8c
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The follicular helper T cells (T-FH) seemed to be expressed in several subsets of T-cell lymphomas. However, their expression in cutaneous T-cell lymphomas (CTCLs) has been rarely described. We investigated the clinical features, histopathological morphology, and expression of T-FH markers in CTCLs. Forty-nine patients (24 men and 25 women) diagnosed with CTCL were examined, 25 patients with mycosis fungoides (MF) and 24 with other CTCLs. Immunohistochemical staining for CD10, Bcl-6, inducible costimulator, CXCL13, and PD-1 were performed. Relation between PD-1 and clinical course in MF was evaluated. PD-1 was detected in 21 of 25 (84.0%) MF cases and in 11 of 24 (45.8%) other CTCL cases. Bcl-6, CXCL13, inducible costimulator, and CD10 were occasionally expressed in most T-cell lymphomas, including MF. The staining for PD-1 was negative in all the MF cases with large-cell transformation. No correlation was observed between disease course and PD-1 expression rate in the MF cases. In conclusion, among the T-FH markers, PD-1 was most frequently expressed in CTCL. PD-1 was expressed in most MF. PD-1 expression rates were significantly higher in MF than in other CTCLs.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 50 条
[31]   Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20 [J].
Frings, Verena G. ;
Roth, Sabine ;
Riedmiller, Anna-Liisa ;
Schaefer, Kristina ;
Goebeler, Matthias ;
Rosenwald, Andreas ;
Geissinger, Eva ;
Wobser, Marion .
ACTA DERMATO-VENEREOLOGICA, 2017, 97 (04) :534-536
[32]   MULTIINSTITUTIONAL STUDY OF CUTANEOUS T-CELL LYMPHOMA AND ADULT T-CELL LEUKEMIA-LYMPHOMA [J].
NAGATANI, T ;
MIYAGAWA, K ;
BABA, N ;
FUKAYA, T ;
HAMADA, T ;
HIRONE, T ;
HISADOME, H ;
HONBO, S ;
HORI, Y ;
IMAMURA, S ;
INOUE, S ;
ITO, M ;
IWATSUKI, K ;
JOHNO, M ;
KOBAYASHI, H ;
KUROKI, Y ;
MIYAMOTO, H ;
NAKAJIMA, H ;
NAKAYAMA, J ;
OKAWARA, A ;
OGATA, K ;
ONO, T ;
SATO, Y ;
TAKATA, M ;
TAKEZAKI, S ;
TASHIRO, M ;
YAMAGUCHI, S ;
YAMADA, M .
EUROPEAN JOURNAL OF DERMATOLOGY, 1994, 4 (04) :299-303
[33]   Follicular cutaneous T-cell lymphoma: a clinicopathological study of nine cases [J].
Hodak, E ;
Feinmesser, M ;
Segal, T ;
Yosipovitch, G ;
Lapidoth, M ;
Maron, L ;
Bergman, R ;
Sahar, D ;
David, M .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (02) :315-322
[34]   Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: Diagnostic implications [J].
Hsi, Andy C. ;
Lee, Sena J. ;
Rosman, Ilana S. ;
Carson, Kenneth R. ;
Kelley, Amanda ;
Viele, Valerie ;
Pang, Xiaofan ;
Musiek, Amy ;
Schaffer, Andras .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (01) :159-167
[35]   Regulation of T-Plastin Expression by Promoter Hypomethylation in Primary Cutaneous T-Cell Lymphoma [J].
Jones, Christine L. ;
Ferreira, Silvia ;
McKenzie, Robert C. T. ;
Tosi, Isabella ;
Caesar, Jacqueline A. ;
Bagot, Martine ;
Whittaker, Sean J. ;
Mitchell, Tracey J. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (08) :2042-2049
[36]   Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma [J].
Begue, Elodie ;
Jean-Louis, Francette ;
Bagot, Martine ;
Jauliac, Sebastien ;
Cayuela, Jean-Michel ;
Laroche, Liliane ;
Parquet, Nathalie ;
Bachelez, Herve ;
Bensussan, Armand ;
Courtois, Gilles ;
Michel, Laurence .
BLOOD, 2012, 120 (01) :143-154
[37]   Evaluating mogamulizumab in the treatment of primary cutaneous T-cell lymphoma [J].
Oymanns, M. ;
Elsayad, K. ;
Wilms, L. ;
Dimmers, F. ;
Daum-Marzian, M. ;
Abu-Dawud, R. ;
Motiei, M. ;
Assaf, C. .
IMMUNOTHERAPY, 2025, 17 (08) :551-559
[38]   Variability in the Expression of Immunohistochemical Markers: Implications for Biomarker Interpretation in Cutaneous T-Cell Lymphoma [J].
Rahbar, Ziba ;
Li, Shufeng ;
Tavallaee, Mahkam ;
Novoa, Roberto A. ;
Kim, Jinah ;
Kim, Youn H. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) :1204-1206
[39]   The Role of the Gut Microbiome in Non-Hodgkin Lymphoma (NHL): A Focus on Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Cutaneous T-Cell Lymphoma, and NK/T-Cell Lymphoma [J].
Lyko, Magdalena ;
Maj, Joanna ;
Jankowska-Konsur, Alina .
CANCERS, 2025, 17 (10)
[40]   Nanopore Sequencing for T-Cell Receptor Rearrangement Analysis in Cutaneous T-Cell Lymphoma [J].
Cieslak, Cassandra ;
Hain, Carsten ;
Rueckert-Reed, Christian ;
Busche, Tobias ;
Klages, Levin Joe ;
Schaper-Gerhardt, Katrin ;
Gutzmer, Ralf ;
Kalinowski, Joern ;
Stadler, Rudolf .
CANCERS, 2024, 16 (21)